Detalles de la búsqueda
1.
Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications.
Curr Opin Infect Dis
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38726832
2.
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial.
Biol Blood Marrow Transplant
; 26(2): 316-322, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605823
3.
The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s).
Transfus Apher Sci
; 59(4): 102766, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32276862
4.
Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation.
Haematologica
; 104(11): 2155-2163, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467131
5.
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
Proc Natl Acad Sci U S A
; 113(41): E6219-E6227, 2016 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27671648
6.
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Transpl Infect Dis
; 20(4): e12906, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29668124
7.
New-Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine-Induced Thrombotic Thrombocytopenia.
Liver Transpl
; 28(2): 314-316, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416086
8.
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.
Blood
; 125(18): 2855-64, 2015 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25742699
9.
Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature.
Transfus Apher Sci
; 61(5): 103448, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422345
10.
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Biol Blood Marrow Transplant
; 22(1): 119-24, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341397
11.
Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation.
Transfusion
; 56(5): 1096-1100, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021516
12.
Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.
Biol Blood Marrow Transplant
; 21(3): 429-39, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25579888
13.
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Cancer
; 121(11): 1809-16, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25649994
14.
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 99(5): 1149-1150, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185463
15.
Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(9): 1444-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24907625
16.
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Biol Blood Marrow Transplant
; 20(3): 382-6, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24321747
17.
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
Biol Blood Marrow Transplant
; 20(5): 724-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24530426
18.
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Biol Blood Marrow Transplant
; 20(10): 1560-5, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933658
19.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24315846
20.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24108528